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MicroRNAs are well known to mediate translational
repression and mRNA degradation in the cytoplasm.
VariousmicroRNAs have also been detected inmem-
brane-compartmentalized organelles, but the func-
tional significance has remained elusive. Here, we
report that miR-1, a microRNA specifically induced
during myogenesis, efficiently enters the mitochon-
dria where it unexpectedly stimulates, rather than re-
presses, the translation of specific mitochondrial
genome-encoded transcripts. We show that this
positive effect requires specific miR:mRNA base-
pairing and Ago2, but not its functional partner
GW182, which is excluded from the mitochondria.
We provide evidence for the direct action of Ago2
in mitochondrial translation by crosslinking immuno-
precipitation coupled with deep sequencing (CLIP-
seq), functional rescue with mitochondria-targeted
Ago2, and selective inhibition of the microRNA
machinery in the cytoplasm. These findings unveil a
positive function ofmicroRNA inmitochondrial trans-
lation and suggest a highly coordinated myogenic
program via miR-1-mediated translational stimula-
tion in the mitochondria and repression in the
cytoplasm.INTRODUCTION
The function and mechanism of microRNAs (miRNAs) have been
well studied in higher eukaryotic cells. miRNAs bind their tar-
get mRNAs via partial base-pairing within the RNA-induced
silencing complexes (RISC) and regulate both mRNA stability
and translation (Carthew and Sontheimer, 2009; Chekulaeva
and Filipowicz, 2009). miRNA-mediated RNA degradation canbe accomplished via a slicing-competent Ago protein (Ago2 in
mammals) to cleave target mRNA in the mRNA:miRNA duplex.
The broad function of RISC in translational control is mediated
by the key Ago partner GW182 to recruit deadenylating/decapp-
ing enzymes to allow exonucleases to attack unprotectedmRNA
and repress translation through competing with the cap binding
protein eIF4E and/or interfering with ribosome scanning (Czech
and Hannon, 2011).
Besides their primary functions in translational repression,
miRNAs have also been implicated in enhancing translation
under specific cellular conditions (Vasudevan, 2012). This was
first observed in serum-starved cells (Vasudevan et al., 2007),
but such an opposite function of miRNAs has not been widely
appreciated, partly because the potential mechanism involved
has remained largely unclear. Biochemical experiments with fly
extracts provided some initial hint to this unconventional miRNA
function, showing that a target mRNA lacking both cap and
typical poly(A) tail permits enhanced translation when themiRNA
is assembled into a complex with a GW182-detached Ago pro-
tein (Iwasaki and Tomari, 2009). Related phenomena have also
been observed in immature oocytes where the miRNA machin-
ery is either in an inactive state (Suh et al., 2010) or even stimu-
lates translation of target transcripts (Mortensen et al., 2011).
The miRNA machinery is known to primarily act in the cyto-
plasm. However, growing evidence suggests that both miRNAs
and proteins of the Argonaute family also play important roles in
transcriptional control (Cernilogar et al., 2011; Guang et al., 2008)
and DNA repair (Wei et al., 2012). miRNAs have also been de-
tected in membrane-bound compartments, such as secreted
vesicles (Zhang et al., 2010) and mitochondria (Bandiera et al.,
2011; Barrey et al., 2011; Das et al., 2012; Kren et al., 2009; Sri-
pada et al., 2012). The presence of miRNAs in the mitochondria
is somewhat surprising because mitochondria maintain their
own genome, and in many aspects, resemble bacteria (Taan-
man, 1999); however, the functional significance of miRNAs in
the mitochondria has remained largely unknown. One report in-
dicates that miR-181c could repress the translation of a mito-
chondrial transcript, but paradoxically, reduced translation ledCell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc. 607
Figure 1. Increased Mitochondrial Proteins
without a Significant Elevation in mtDNA
Copy Number or Transcription
(A) Levels of COX1 and ND1 proteins detected by
western blotting and miR-1 by Northern blotting in
different adult mouse tissues. Levels of Histone H3
and 5S rRNA served as protein and RNA loading
controls, respectively.
(B) Western and TaqMan PCR analysis of COX1,
ND1, and miR-1 in C2C12 cells before and after
differentiation. Pan actin and VDAC served as
protein loading controls and 28S rRNA as an RNA
loading control. MHC was analyzed as a control for
the induction of the myogenic program. Tfam and
TACO1 were analyzed to detect potential regula-
tion of critical mitochondrial transcriptional and
translational regulators.
(C–E) Quantification of proteins normalized to pan
actin (C), mtDNA normalized to nuclear DNA (D),
and RNA normalized to GAPDH, (E) during C2C12
cell differentiation. Data in (C) and (E) are based on
three biological repeats and data in (D) on ten
biological repeats. Errors bars are mean ± SD.
See also Figure S1.to an overall enhancement of mitochondrial activities in ventric-
ular myocytes (Das et al., 2012).
Our current study was initially geared to investigate a puzzle
that mitochondrial DNA (mtDNA)-encoded proteins were greatly
elevated during muscle differentiation, but without a significant
increase in mtDNA copy number or transcription. This leads to
an unexpected finding that the muscle-specific miR-1 is able
to stimulate mitochondrial translation of multiple mtDNA-
encoded transcripts, while repressing its nuclear DNA-encoded
targets in the cytoplasm. Such a miRNA-dependent effect re-
quires Ago2, but not its normal functional partner GW182,
consistent with the presence of a significant amount of Ago2,
but not GW182, in the mitochondria. These findings provide crit-
ical insights into miRNA action mechanisms, functional conser-
vation of the Argonaute family of proteins in diverse organisms,
change in bioenergetics mechanisms during cell differentiation,
and the regulation of mitochondrial translation in higher eukary-
otic cells.
RESULTS
Marked Increase in Mitochondrial Protein Synthesis
during Muscle Differentiation
Mitochondria generate ATP through oxidative phosphorylation
to provide the chemical form of energy for cellular activities (Sar-
aste, 1999). The energy demand is especially high in cardiac and
skeletal muscle (Lopaschuk et al., 2010; Moyes et al., 1997).
Consistently, we detected much higher levels of mtDNA-
encoded proteins in muscle cells relative to constant amounts608 Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc.of nuclear DNA-encoded histone H3 pro-
tein and 5S rRNA in different mouse tis-
sues (Figure 1A). Such a marked increase
was also evident during C2C12 cell differ-
entiation from myoblasts to myotubes,characterized by the induction of the myosin heavy chain
(MHC) and the muscle-specific miRNA miR-1 (Chen et al.,
2006; Rao et al., 2006). However, both actin and the nuclear
DNA-encoded, mitochondrial residential protein VDAC were
constant (Figure 1B). Quantitative analysis indicates that the
mitochondrial ND1 and COX1 proteins were increased by more
than 15-fold during C2C12 cell differentiation (Figure 1C).
Significantly, such a dramatic elevation in protein synthesis
was not accompanied by mtDNA replication during C2C12 cell
differentiation (Figure 1D), as reported earlier (Franko et al.,
2008). The mRNA levels for both COX1 and ND1 were also
invariant (Figure 1E), which was further confirmed by RT-qPCR
with three distinct primer sets (Figure S1 available online). This
is consistent with little change in TFAM expression (Figure 1B),
a vital transcriptional activator in the mitochondria (Bestwick
and Shadel, 2013). Because we did not detect any induction of
TACO1 (Figure 1B), a major translational activator for COX1
(Weraarpachai et al., 2009), these data suggest a previously un-
known mechanism that may account for induced mitochondrial
translation during muscle differentiation.
Evidence for the Presence of Ago2 within the
Mitochondria
Given the recent observations that various miRNAs were
detected in isolated mitochondria from rat liver (Kren et al.,
2009), rat ventricular myocytes (Das et al., 2012), and several
common human cell lines (Sripada et al., 2012), we reasoned
that reducedmiRNA targeting to themitochondriamight account
for increased translation in the mitochondria during muscle
Figure 2. Detection and Quantitative Analysis of Ago2 and miR-1 in the Mitochondria
(A) Trypsin protection analysis of purified mitochondria (MT) and mitoplasts (MP) from adult mouse heart, C2C12 myoblasts, and C2C12 myotubes. See also
Figure S2A.
(B) Quantification of Ago2 and miR-1 per C2C12 nucleus or per mitochondrial genome. The average number is based on two independent experiments. See also
Figures S2C and S2D.
(C) Nuclease protection analysis. Three aliquots of purified mitochondria and mitoplasts were treated with isolation buffer, with RNase T1 (RN) plus MNase (MN),
or with the combination of nucleases in the presence of Triton X-100. Data are based on triplicated experiments and error bars are means ± SD.
(D) Purifiedmitochondria andmitoplasts from the same fractionation experiment were first characterized by the lack of the ERmarker ERp72, but the presence of
outer membrane protein marker Tom20 in the mitochondria and the inner membrane marker NDUFB8 in both mitochondria and mitoplasts (bottom). Equal
amounts of purified mitochondria and mitoplasts based on the levels of 16S rRNA were subjected to ribo-IP with anti-Ago2 or control IgG (top). Western blotting
data showed specific anti-Ago2 IP. Individual mitochondrial transcripts were examined by semiquantitative RT-PCR.
See also Figures S2E and S2F for real-time RT-PCR analysis of Ago2-associated mitochondrial transcripts from purified mitoplasts.differentiation. Alternatively, enhanced mitochondrial translation
may indirectly result from repression of some nuclear DNA-
encoded mitochondrial translational repressors, in line with
the induction of Ago2 expression during C2C12 differentiation
(Figure 1B).
To begin to explore these possibilities, we first used highly
purified mitochondria to rigorously demonstrate that a frac-
tion of Ago2 is indeed present within the mitochondria.
Because purified mitochondria are often contaminated with
endoplasmic reticulum (ER) proteins due to the intimate
association between ER and the mitochondria (de Brito and
Scorrano, 2008; Rizzuto et al., 1998), we selectively removed
the outer membrane by treating purified mitochondria (MT)
with digitonin to prepare mitoplasts (MP) from mouse heart
or C2C12 cells before and after differentiation (Bosmann
et al., 1972; Schnaitman and Greenawalt, 1968). We found
that our initially purified mitochondria were largely free of ERcontamination as indicated by the absence of the ER-specific
protein ERp60 or ERp72 (Figure 2A). Upon digitonin treat-
ment followed by sedimentation or fractionation on a sucrose
gradient, the outer membrane was removed, as evidenced by
the lack of Tom20, but the inner membrane was largely intact,
as indicated by the presence of the inner membrane marker
NDUFB8 and the mitochondrial matrix protein HSP60 (Figures
2A and S2A).
Under these rigorously controlled conditions, we detected
Ago2 in both highly purified MT and MP, which became
Trypsin-sensitive only when the innermembranewas further per-
meabilizedwith Triton X-100. Neither Ago1 nor Ago3was detect-
able in MT and MP (Figure S2A), indicating that Ago2 may be
selectively imported into the mitochondria. Tandem mass spec-
trometric analysis confirmed the identity of Ago2 immunoprecip-
itated from MP (Figure S2B). These data agree with the recent
confocal microscopic result (Bandiera et al., 2011) and provideCell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc. 609
the strongest biochemical evidence to date for the presence of
Ago2 inside the mitochondria.
Quantification of Ago2 in the Mitochondria during
Muscle Differentiation
We next wished to quantitatively determine the levels of Ago2 in
the mitochondria during C2C12 cell differentiation by using the
standard curve generated with Ago2 expressed in insect cells
(Figures S2C and S2D). Because induced myotubes contain
more than one nucleus, we determined the copy number of
nuclear DNA by qPCR to calculate the number of Ago2
molecules per nuclear genome. This revealed 1.34 3 105 and
7.35 3 105 Ago2 molecules in C2C12 myoblasts and myotubes,
respectively (Figure 2B), which is similar to the recent estimate of
1.4 3 105–1.7 3 105 Ago2 per cell on a human melanoma cell
line (Wang et al., 2012).
We then determined the amount of Ago2 within the mito-
chondria by using mtDNA as an internal control (the copy
number of mtDNA varies from 0 to 11 per mitochondria with
the average = 2) (see Cavelier et al., 2000), which is neces-
sary because of potential damage during MP preparation.
This analysis revealed 31 and 314 Ago2 molecules, respec-
tively, per mtDNA in C2C12 cells before and after differen-
tiation (Figure 2B). We also determined the ratio of mitochon-
drial and nuclear DNA in our cellular system, revealing a ratio
of 554 in myoblasts and 774 in myotubes, thus suggesting
the presence of 31 3 554/1.34 3 105 = 12.8% and 314 3
774/7.35 3 105 = 33.1% of total cellular Ago2 in the mitochon-
dria of C2C12 cells before and after differentiation, respec-
tively. These quantitative data suggest that more Ago2 is
targeted to the mitochondria upon C2C12 differentiation into
myotubes.
Efficient Entry of InducedmiR-1 into theMitochondria of
Muscle Cells
We similarly analyzed the quantity of miR-1 in the mitochondria
by using highly purified mitoplasts, finding that a fraction of the
newly induced miR-1 was indeed detectable inside the mito-
chondria of myotubes, which became sensitive to nuclease
only in the presence of Triton X-100 (Figure 2C). The nuclease
sensitivity of miR-1 was similar to the mitochondrial 16S rRNA.
In contrast, both nuclear U6 small nuclear RNA (snRNA) and
cytoplasmic GAPDH mRNA were largely removed from purified
MT and MP, and any residual amounts could be fully degraded
by a combination of RNase T1 (RN) and Micrococcal nuclease
(MN) in the absence of detergent (Figure 2C). We further showed
that our mitoplasts were highly purified away from the abundant
7SK noncoding RNA and multiple nuclear DNA-transcribed
mRNAs for mitochondrial residential proteins (e.g., NDUFB8,
COX4V1, and NDUFV1) (Figure S2E).
Using the same quantification strategy for Ago2, we deter-
mined the amount of miR-1 in the mitochondria, revealing
5.9 3 104 miR-1 per nuclear genome in myotubes (note that
miR-1 was not detectable in myoblasts), 31.5 per mtDNA, and
a total amount of 31.53 775/5.93 104 = 41.4% in the mitochon-
dria. Therefore, similar to Ago2, miR-1 is not only present in the
mitochondria in a substantial quantity, but also increased, rather
than decreased, during muscle cell differentiation.610 Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc.Having thoroughly demonstrated the presence of both Ago2
and miR-1 in the mitochondria, we next performed Ribo-IP to
determine whether Ago2 is associated with mitochondrial tran-
scripts. Using consecutively purified MT and MP (characterized
in the bottom of Figure 2D) from the same cell population, we
found that anti-Ago2, but not control IgG, efficiently captured
multiple mitochondrial transcripts (Figure 2D, top). These semi-
quantitative results were further conformed by RT-qPCR with
RNA recovered from purified mitoplasts (Figure S2F). Therefore,
in contrast to our initial expectation, the miRNA machinery
appears to become increased, rather than decreased, in the
mitochondria of differentiated C2C12 cells.
Identification of Specific miR-1 Targets in C2C12 Cells
To determine specific targets for Ago2 and miR-1, we first de-
signed a miRACE strategy to experimentally identify specific
miRNA targets (Figure S3A), instead of relying on computational
prediction, which is analogous to a published method (Easow
et al., 2007). In this procedure, miRNA:mRNA duplexes were
captured from whole-cell extracts with anti-Ago2 followed by
in situ extension of endogenous miRNA into target mRNA with
reverse transcriptase. The extended products were poly(C)-
tailed at the 30 end and PCR-amplified using a common primer
linked to a poly(G) sequence and amiRNA-specific primer. While
we are still refining this method for high-throughput analysis, we
initially focused on identifying miR-1 targets by cloning and
sequencing a sizable number of PCR products. This revealed
that several cytoplasmic targets for miR-1, one of which (ELL2)
was further validated (see below). Importantly, we identified mul-
tiple mitochondrial transcripts for this miRNA (Figure S3B).
The second approachwe tookwas tomap specific Ago2 bind-
ing events by crosslinking immunoprecipitation coupled with
deep sequencing (CLIP-seq). We performed duplicated CLIP-
seq on C2C12 myoblasts and myotubes, obtaining 10 million
uniquely mapped tags from each CLIP-seq library, which
showed high concordance within the same cell types and large
differences between the two cell types (Figure S3C). Compiling
the normalized Ago2 binding events (to 1 million) on potential
miR-1 cytoplasmic targets predicted by the miRNA target pre-
diction program PITA (Kertesz et al., 2007), we observed no
enrichment on myoblasts, but significant enrichment on myo-
tubes, consistent with induced miR-1 only in myotubes (Fig-
ure 3A). Of five most characterized cytoplasmic miR-1 targets
reported in the literature, four showed a dramatic increase in
Ago2 binding on the target sites (Figure 3B). HDAC4 exhibited
an Ago2 peak before C2C12 differentiation, indicative of the
involvement of another miRNA(s), but the Ago2 level was further
enhanced after C2C12 differentiation (Figure 3B). Together,
these data demonstrated the robustness of our CLIP-seq data
in pinpointing specific miRNA targeting sites in the nuclear
genome.
Critical Insights from Mapped Ago2-RNA Interactions in
the Mitochondria
We then turned our attention to Ago2 interaction with the mito-
chondrial genome. Because the nuclear genome is populated
with multiple mitochondrial pseudogenes, we took extra caution
in mapping CLIP-seq tags to mtDNA by dividing the CLIP-seq
tags into three classes that were (1) uniquely mapped to mito-
chondrial transcripts from mtDNA, (2) uniquely mapped to
mitochondrial pseudogenes in the nuclear genome, and (3)
commonly mapped to both nuclear and mitochondrial genomes
(Table S1). This analysis revealed that the number of tags
uniquely mapped to the nuclear mitochondrial pseudogenes is
largely negligible. We therefore combined tags from class 1
and 3 (Table S2) to generate an Ago2 interactionmap in themito-
chondria. Significantly, we observed dramatic induction of Ago2
binding to multiple specific mitochondrial transcripts upon
C2C12 differentiation (Figure 3C).
A major technical concern is potential contamination of abun-
dant mitochondrial transcripts during immunoprecipitation,
whichmight be the reason that most published CLIP-seq studies
ignored tags that were mapped to mitochondrial transcripts. To
address this problem, we analyzed crosslink-induced mutation
sites (CIMS), which is known to occur in internal regions, while
insertions and point mutations due to sequencing errors are typi-
cally distributed at both ends (Zhang and Darnell, 2011) (Fig-
ure S3D). The CIMSs (blue tags on the opposite side of red
CLIP tags) were largely concordant with the distribution of the
CLIP tags mapped on mitochondrial transcripts, thus confirming
direct interactions (Figure 3C).
Importantly, using the PITA program, we identified potential
target regions for the two most highly induced miR-1 (green
bars) and miR-206 (red bars), which shared related seed se-
quences. Two of these predicated sites exactly match the
miRACE-identified target sites for miR-1 in ND1 and COX1
(blue bars in Figure 3C). These candidate miR-1 target sites
correspond to multiple induced Ago2 CLIP-seq peaks. Specif-
ically, we noted a major Ago2 CLIP-seq peak on ND1 (peak 1),
another major peak on ATP8 (peak 3), multiple peaks on COX3
(peak 4), two small peaks on ND5 (peak 5 and 6), and one
peak on cytb (peak 7) (Figure 3C). Interestingly, Ago2 seems to
prevalently interact with 12S mitochondria-specific rRNA (Rrn1)
in myoblasts, which was further induced after C2C12 dif-
ferentiation to myotubes. Furthermore, Ago2 also shows broad
interactions with multiple mitochondrial transcripts, including
COX1, which contains a miR-1 target that had been both pre-
dicted and experimentally mapped. This broad binding pattern
implies either multiple miRNA:mRNA interactions and/or some
distinct functional properties of Ago2 in the mitochondria (see
Discussion).
Polysome Profiling of Mitochondrial Translation during
Muscle Differentiation
A gold standard for studying translational control is through poly-
some profiling, a routine for investigating cytoplasmic transla-
tion, but a major challenge for detecting potential polysomes
from the mitochondria partly because of coupled transcription/
translation on the inner membrane (Bestwick and Shadel,
2013; Bonawitz et al., 2006). By optimizing the protocol for mitor-
ibosome fractionation, we detected both small (28S) and large
(39S) ribosome fractions as well as monosomes (55S) on a
10%–30%sucrose gradient, which is characterized by the distri-
bution of 12S and 16S rRNAs and their associated ribosome
proteins (MRPS27 and MRPL24) (Figure 3D). These profiles
resemble closely to those reported in the literature (Antonickaet al., 2013; Surovtseva et al., 2011). Interestingly, we also
detected putative polysomes near the bottom of the gradient
(fractions 12 and 13) on both C2C12 myoblasts and myotubes,
which could be converted to monosomes by RNase I treatment
(Figure 3D).
Importantly, we observed that Ago2 cosediments with 28S
and 39S ribosomes, and to a less extent, withmonosomes or po-
tential polysomes on myoblasts, and such distribution became
broadened on myotubes, indicative of additional induced inter-
actions (Figure 3D). This is consistent with Ago2 CLIP-seq sig-
nals on 12S rRNA in myoblasts and, to a less extent, 16S rRNA
in myotubes (see Figure 3C). Significantly, by RT-qPCR quantifi-
cation of ND1 and COX1mRNAs and plotting the data according
to percent distribution on the gradient, we found that both mito-
chondrial transcripts showed increased association with the pu-
tative polysome fractions from myotubes relative to myoblasts.
These data provide initial support to enhanced mitochondrial
translation upon C2C12 cell differentiation.
Opposite Functions of miR-1 in the Cytoplasm versus
Mitochondria
To determine the precise role of miR-1 in mitochondrial transla-
tion, we first validated the expected effect of miR-1 on repres-
sing translation of its cytoplasmic target HDAC4 (Chen et al.,
2006) and the newly identified target ELL2 (Figure 4A). Interest-
ingly, we detected the opposite effects of miR-1 on mitochon-
drial ND1 and COX1 transcripts in undifferentiated C2C12 cells,
which showed increased, rather than decreased, translation,
while the level of COX2 was unaffected (Figure 4B). Using
Ago2 knockout mouse embryonic fibroblasts (MEFs), we
demonstrated that the miR-1 effects on both COX1 and ND1
were Ago2-dependent (Figure 4C).
To further characterize this positive effect, we performed a
converse experiment using an antagomir to block miR-1 in
C2C12 myotubes (Figure 4D). While antagomir-1 had little effect
on ND1 and COX1 proteins before miR-1 induction in C2C12
myoblasts, the miR-1 inhibitor diminished miR-1 expression de-
tected by Northern and blocked enhanced ND1 and COX1 trans-
lation measured by western blotting (Figure 4D). Consistent with
the regulation at the translational level, little difference was
detected on the mRNA level for both of these mitochondrial
transcripts (Figure 4D, bottom). We could also prevent miR-1-
dependent translational enhancement by coexpressing a
miR-1 sponge in the cytoplasm (Figure S4A).
As expected, the activities of ND1-containing Complex I and
COX1-containing Complex IV were both elevated in miR-1
transfected myoblasts (Figure 4E). ATP production was also
enhanced upon C2C12 differentiation, which was significantly
attenuated by antagomir-1 (Figure 4F). Despite relatively modest
enhancement in these assays, which might be due to uncoordi-
nated induction of other respiratory chain components in miR-1
transfected cells, these results linked miR-1 enhanced transla-
tion to increased respiratory activities.
Base-Pairing Requirement for miR-1-Induced
Mitochondrial Translation
To understand how miR-1 enhances mitochondrial translation,
we first asked if there is anything unusual about the miR-1Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc. 611
(legend on next page)
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targeting site in ND1 or COX1. We found that, as expected, the
target sites cloned in the 30 UTR of a luciferase reporter mediated
translational repression in the cytoplasm, and a mutant miR-1
lost the effect, which could be reversed by reverting the target
sequences in the reporter to restore base pairing (Figures S4B
and S4C). The stimulating effect of miR-1 did not seem to result
from induced myogenesis or increased mtDNA replication (Fig-
ures S4D–S4F). We also found that miR-1 was able to enhance
ND1 translation (Figure 4G) and ATP production (Figure 4H) in
nonmyogenic HeLa cells. These data argue against enhanced
mitochondrial translation as an indirect result of the induced
myogenic program.
The mapped miR-1 target sites in both ND1 and COX1 fulfill
the established base-pairing rule formiRNA targeting (Figure 5A).
The seed regions in both COX1 and ND1 appear to be more
conserved during evolution compared to those in the middle
and the 30 side (Figure S5A). We mutated either the seed region
or the 30 sequence and found that bothmutations abolishedmiR-
1-inducedND1 andCOX1 translation (Figures 5A and 5B). Again,
the mRNA levels remained unaltered, and neither wild-type
miR-1 nor its mutants exhibited detectable effect on the nuclear
DNA-encoded mitochondrial protein COX4 (Figure 5B).
Direct Action of miR-1 in Mitochondrial Translation
We took two additional strategies to further demonstrate the
direct act of miR-1 within the mitochondria. We designed two
separate miRNA mimics with altered targeting specificities.
miR-COX1wouldmore efficiently target COX1, with reduced po-
tential in targeting ND1, while miR-ND1 would only target ND1
(Figure 5C). The specificity of these designer miRNA mimics
was confirmed on their cytoplasmic reporters (Figures S5B and
S5C). In transfected C2C12 myoblasts, we found that miR-
COX1 elevated COX1, with less effect on ND1, and as expected,
miR-ND1 only stimulated ND1 (Figure 5D). We also tested
another miRNA miR-101, which targets a specific region in
ND1, and miR-499-5p, which targets a different region in ND1
(Figure 5E). We found that both exclusively enhanced ND1 trans-
lation, while several nontargeting miRNAs tested lacked the
effect (Figure 5F). Because it is unlikely that specific miRNA
mimics all caused the same indirect effects in the cytoplasm toFigure 3. Mapping of Ago2-RNA Interactions by CLIP-Seq and Analysi
(A) Ago2 CLIP-seq profiles on predicted miR-1 targets before and after C2C12 di
the center of PITA predicted miR-1 target sites.
(B) Ago2 CLIP tags on known cytoplasmic targets for miR-1 before (top) and after
shown on the top of each panel. Red, CLIP tags; blue, CIMS tags.
(C) The distribution of Ago2 CLIP-seq tags in themitochondrial genome before and
PITA predicted target sites for miR-1 (green) and miR-206 (red) are indicated right
(dark blue) are separately mapped to the mitochondrial genome in C2C12 myo
differentiation media (DM) for 4 days. The locations of miRACE identified miR-1
(D) Analysis of mitochondrial translation by polysome profiling. Purified mitoch
cytoplasmic ribosomes, as indicated by the lack of western blotting for repre
mitochondrial ribosomal proteins (MRPS27 andMRPL24) and Ago2 on individual
and miRNA transcripts were quantified by real-time RT-PCR (TaqMan for miR-
putative polysomes was based on the distribution of both rRNAs and proteins a
polysome fractions were characterized by RNase I treatment. The relative abundan
the total fraction. The increased polysome association of ND1 and COX1 transcr
myoblasts to myotubes.
See also Figure S3.stimulatemitochondrial translation, these data support the direct
act of multiple miRNAs in enhancing mitochondrial translation.
To provide decisive evidence, we took advantage of Ago2
knockout MEFs to functionally rescue miR-1-dependent mito-
chondrial translation with either HA-tagged Ago2 or mitochon-
dria-targeted Ago2 that carries a specificmitochondrial targeting
signal peptide (su9). Confocal microscopy confirmed the coloc-
alization of Su9-HA-Ago2 with Mito-GFP, a well-established
marker for the mitochondria (Chen et al., 2003), while HA-Ago2
was diffusely localized in the cytoplasm (Figure 5G). Using an
RNAi-based luciferase reporter containing a perfect comple-
mentary sequence to miR-1, we found that the reporter was
potently suppressed in wild-type, but not in Ago2 knockout
MEFs (Figure 5H, top). Exogenous HA-Ago2 rescued the RNAi
effect and restored miR-1-enhanced translation of ND1 and
COX1, and in sharp contrast, mitochondria-targeted Su9-HA-
Ago2 could not rescue the RNAi effect in the cytoplasm, but
potently restored the effect of miR-1 in the mitochondria (Fig-
ure 5H). Together with the specificity switch experiments, these
data demonstrate the direct effect of miR-1 in enhancing mito-
chondrial translation.
Differential Sensitivity to Cytoplasmic and
Mitochondrial Translational Inhibitors
Thus far,wehadmeasured thesteadystate levelsofmitochondrial
proteins to infer miR-1 regulated translation. To directly demon-
strate enhanced mitochondrial translation, we used the methio-
nine analog AHA to metabolically label nascent proteins in the
mitochondria while blocking cytoplasmic translation by Emetine
(Weraarpachai et al., 2009). In this experimental setting, C2C12
myoblasts were first transfected with miR-1 and then switched
to the media containing Emetine. AHA was next added to allow
its incorporation into nascent polypeptides, which were subse-
quently labeled by the reaction with fluorescent alkyne and
resolvedonSDS-PAGE.Asexpected, Emetineplus themitochon-
drial translation inhibitor Chloramphenicol (INN) potently blocked
all translation activities in the cell (Figure 6A, lanes 3 and 4).
In the presence of Emetine, but absence of INN, we detected
translation products of all mtDNA-encoded transcripts. Com-
pared to loading controls, we noted some general enhancements of Mitochondrial Translation by Polysome Profiling
fferentiation. Duplicated data in each cell type were individually plotted against
(bottom) C2C12 differentiation. The chromosomal location of each target site is
after C2C12 cell differentiation. The annotated genes are displayed on the top.
below the gene track. The CLIP tag distribution (red) and corresponding CIMS
blasts cultured in growth media (GM) and in C2C12 myotubes maintained in
target sites are indicated between the two CLIP panels.
ondria were used for fractionation on a sucrose gradient, which was free of
sentative cytoplasmic ribosomal proteins (RPS3 and RPL4). Representative
gradient fractions were detected by western blotting and specific rRNA, mRNA,
1). The assignment of small and large ribosomal subunits, monosomes, and
nd comparison with published mitochondrial polysome profiles. The putative
ce of individual transcripts in each fractionwas presented as the percentage of
ipts is highlighted with dark blue bars proportional to their enhancement from
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Figure 4. Opposite Effects of miRNAs on Translation in the Cytoplasm versus Mitochondria
(A) Western blotting of HDAC4 and ELL2 in C2C12 myoblasts after transfection with miR-1 or control siRNA.
(B) Western blotting of ND1 and COX1 in C2C12 myoblasts 48 hr after transfection with control RNA or miR-1.
(C) ND1 and COX1 protein levels in wild-type and Ago2 knockout MEFs transfected with either control RNA or miR-1.
(D) Antagomir-1 blocked miR-1 expression and diminished enhanced ND1 and COX1 translation in myotubes. In this experiment, C2C12 myoblasts were first
transfected with control RNA or antagomir-1 and subsequently transferred to differentiation media after 24 hr. Western blotting of ND1 and COX1 was performed
after culturing the cells for another 3 days. Actin and 5S rRNA served as loading controls for protein and RNA. The lower panel showed that antagomir-1 had no
effect on the mRNA levels of both ND1 and COX1.
(E) Enhanced activities of Complex I and IV by miR-1 in transfected C2C12 myoblasts.
(F) Antagomir-1 blocked enhanced ATP production in C2C12 myotubes.
(G) miR-1 enhanced ND1 protein synthesis without affecting its mRNA levels in transfected HeLa cells.
(H) miR-1 induced ATP production in transfected HeLa cells.
Data in (D–H) are based on three biological repeats and shown asmean ±SD; p values are indicated in each panel. SpecificmicroRNAmimics and antagomirs are
listed in Table S3. See also Figure S4.of mitochondrial translation by miR-1. In addition, miR-1 mark-
edly enhanced COX1 translation (Figure 6A, compare lanes 5
and 6). We also reproducibly detected enhanced (although to
less degrees) translation of ND1 (note that ND1 was less effi-
ciently labeled, which is a well-known fact) as well as cytb,
COX3, and ATP8 (red arrows in Figure 6A), all of which contain
at least one predicted miR-1 targeting site each underlying a
specific Ago2 CLIP-seq peak (see Figure 3C). In contrast, over-
expressed miR-499-5p had no effect on COX1, but enhanced
ND1 translation (Figure 6A, lanes 7 and 8), consistent with its tar-
geting specificity. We also noted its ability to enhance ND4L
translation, which also contains a predicted miR-499-5p target-
ing site (data not shown). Finally, using INN, we examined and614 Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc.ruled out the potential effect of miR-1 on the protein stability of
ND1 (Figure 6B). Together, these data provide concrete evi-
dence for miRNA-augmented mitochondrial translation.
Potential Mechanism for miRNA-Enhanced Translation
in the Mitochondria
To gain mechanistic insights into miRNA-enhanced mitochon-
drial translation, we followed the clue from a Drosophila study,
which suggests three critical requirement for converting
miRNA-dependent translational repression to activation: (1)
lack of the cap at the 50 end, (2) lack of a typical poly(A) tail at
the 30 end, and (3) detachment of GW182 from an Ago protein
(Iwasaki and Tomari, 2009; Vasudevan, 2012). Interestingly, all
Figure 5. Target-Specific Effect of miRNA and miRNA Mimics
(A) Sequences of miR-1 and its 30 and 50 mutants. Calculated free energy for base-pairing is indicated for wild-type miR-1.
(B) Analysis of C2C12myoblasts transfected with wild-type andmutantmiR-1 bywestern blotting (top) and real-time RT-qPCR (bottom). Data in the bottom panel
are based on triplicated experiments and shown as mean ± SD.
(C) Designer miRNA mimics and their base-pairing potential with COX1 and ND1. According to the calculated free energy, miRCOX1 showed reduced base
pairing with ND1 whereas miRND1 lost the ability to base pair with COX1.
(D) Analysis of C2C12 myoblasts transfected with miRCOX1 and miRND1 by western (top) and specific proteins levels were quantified (bottom). Data are based
on triplicated experiments and error bars are means ± SD.
(E) Base-pairing potentials of a miR-101 and miR-499-5p with distinct regions in the ND1 transcript.
(F) Analysis of C2C12 myoblasts transfected with a panel of miRNAs, two of which (miR-101 and miR-499-5p) enhanced ND1, but not COX1, protein synthesis.
miR-1 effects were analyzed in parallel as a positive control. See also Figure S5.
(G) Confocal microscopic analysis of Ago2 knockout MEFs complemented with HA-Ago2 or mitochondrial targeted Su9-HA-Ago2. Mitochondria was marked by
a cotransfected Mito-GFP.
(H) General and selective rescue of Ago2 functions on Ago2 knockout MEFs. A luciferase reporter containing a perfectly complementary sequence to miR-1 was
analyzed to determine the Ago2-mediated RNAi effect in the cytoplasm (top). The data showed that the RNAi effect could be rescued by HA-Ago2, but not
mitochondria- targeted Su9-HA-Ago2. The expression of tagged Ago2 and the response of ND1 and COX1 translation to transfected miR-1 in different Ago2
complemented MEFs were shown in the middle. The data of triplicated experiments were quantified and shown as mean ± SD with indicated p values (bottom).
Specific microRNA mimics are listed in Table S3.mitochondrial transcripts automatically fulfill the first two re-
quirements because mitochondrial transcripts resemble mRNAs
in prokaryotic cells by having no cap nor typical long poly(A) tail
(Gagliardi et al., 2004; Temperley et al., 2010). This prompted us
to experimentally test the third requirement by determiningwhether GW182 maintains its partnership with Ago2 within the
mitochondria.
We found that, compared to Ago2, GW182 was only detected
in the cytoplasm (Figure 6C). Three GW182 paralogs are
encoded in mammalian genomes, including TNRC6A (thatCell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc. 615
Figure 6. miR-1 Enhanced Protein Synthesis in the Mitochondria
(A) Detection of nascent protein synthesis in the mitochondria when cytoplasmic translation was blocked by Emetine. C2C12 myoblasts were first transfected
with a control RNA or miR-1 or miR-499-5p and protein synthesis was monitored by AHA incorporation in the presence of Emetine. Cytoplasmic actin and
mitochondrial VDAC served as loading controls. Emetine blocked all cytoplasmic translation to allow detection of mitochondrial translational activities. Red
arrows highlight individual elevated bands by miR-1 or miR-499-5p.
(B) Lack of effect of miR-1 on ND1 protein stability. The protein levels were determined in the presence of INN in control and miR-1 transfected C2C12 cells and
the data were normalized against the protein level of ND1 at the 0 time point.
(C) Restriction of GW182 and its paralogs TNRC6B and TNRC6C from the mitochondria. Lamin A/C was purified away from the mitochondria. ND1 and Tom20
served as controls for proteins localized within the mitochondria or associated with the outer membrane of purified mitochondria.
(D) miR-1 enhanced mitochondrial translation when the miRNA machinery was selectively inactivated by knocking down GW182 in the cytoplasm. GW182
showed the expected requirement for miR-1 to act on its cytoplasmic targets HDAC4 and Hand2 (top) and on a cytoplasmic luciferase reporter containing the
miR-1 targeting site in ND1 (bottom). When the function of the miRNA machinery was largely compromised in the cytoplasm of GW182 knockdown cells (using
specific siRNAs listed in Table S3), transfected miR-1 continued to show the ability to enhance ND1 translation in the mitochondria.
(E) Expanded roles of miR-1 in muscle differentiation. miR-1 is known to be induced by SRF, MyoD and Mef2 during differentiation. Induced miR-1 has been
thought to act on its cytoplasmic targets to inhibit cell proliferation via Hand2 and promote cell differentiation through HDAC4 and Mef2. The newly elucidated
function of miR-1 contributes to efficient protein synthesis in the mitochondria, resulting in boosted ATP production to meet the increasing energy demand in
differentiating muscle cells. Therefore, miR-1 mediated translational repression in the cytoplasm and translational enhancement in the mitochondria may
constitute a highly coordinated myogenic program for muscle differentiation and function.
Data in (B) and (D) are based on three biological repeats and shown as mean ± SD with p values indicated in (D).corresponds to GW182), TNRC6B and TNRC6C (Ding and Han,
2007; Jakymiw et al., 2007) and published works indicate that all
function in the miRNA pathway (Liu et al., 2005; Meister et al.,
2005; Zipprich et al., 2009). We found that all three GW182 family
members were excluded from the mitochondria (Figure 6C),
suggesting that the miRNA machinery is rearranged in the
mitochondria.
We took advantage of this mechanistic insight to further test
the selective requirement for GW182 in miRNA-mediated func-
tions in the cytoplasm versus the mitochondria. GW182 has616 Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc.been shown to be required for miRNA-mediated translational
repression in the cytoplasm (Eulalio et al., 2008; Zipprich et al.,
2009). As expected, GW182 knockdown preventedmiR-1-medi-
ated translational repression of its two cytoplasmic targets
HDAC4 andHand2 (Figure 6D, top) aswell as the cytoplasmic re-
porter containing the miRNA target site from ND1 (Figure 6D,
bottom). Under these conditions, GW182 RNAi-treated C2C12
myoblasts continued to show enhanced ND1 translation by
miR-1 (Figure 6D, top). Based on these results, we propose
that the rearranged miRNA machinery, coupled with the
prokaryotic characteristics of the mitochondrial transcripts, is
responsible for translational enhancement in the mitochondria.
DISCUSSION
The findings presented in this article have important implications
in diverse functions of the miRNAmachinery in mammalian cells,
miRNA-mediated switch of energy sources during cellular differ-
entiation and reprogramming, and initiation of mitochondrial
translation, which has been poorly understood despite intensive
efforts in past decades. Below we discuss critical insights into
each of these functional aspects.
Selective Targeting of Ago2 and Specific miRNAs to the
Mitochondria
The presence of the miRNA machinery in the mitochondria was
only recently recognized (Bandiera et al., 2011; Barrey et al.,
2011; Bian et al., 2010; Das et al., 2012; Kren et al., 2009; Sripada
et al., 2012). In the present study, we carefully examined this crit-
ical issue by using highly purified mitoplasts to perform protease
and nuclease protection assays and employed quantitative data
to demonstrate that a significant fraction of Ago2 and miR-1
indeed reside within the mitochondria, especially when C2C12
cells are differentiated into myotubes.
An important question is how Ago2 is able to selectively enter
the mitochondria. A previous study predicted a mitochondrial
targeting sequence near the N terminus of the Ago2 protein
(Bandiera et al., 2011). We fused this sequence to GFP, but failed
to detect its ability to target GFP to the mitochondria (data not
shown). While still a mystery, it is important to note that most
nuclear DNA-encoded mitochondrial proteins do not contain
any identifiable mitochondrial targeting sequences, indicating
the existence of other mechanisms for importing cytoplasmic
proteins into the mitochondria, such as communication between
mitochondria and ER where Ago2 was initially identified (Cikaluk
et al., 1999; Kornmann et al., 2009).
Although 5S rRNA and tRNA can be actively imported into
mitochondria (Mahata et al., 2006; Wang et al., 2010), we do
not know how exactly miRNAs enter the mitochondria. Our
preliminary mitochondrial import assay indicates that multiple
specific and nonspecific miRNAs, but not their precursors,
were able to enter purified mitochondria without the need for
ATP hydrolysis (data not shown). We thus suspect that, while
most miRNAs may be tied up on their cytoplasmic targets,
thus preventing them from free diffusion, a subset of ‘‘free’’
miRNAs, including those newly induced, might enter the mito-
chondria. Clearly, the mechanism for targeting a subset of
miRNAs and specific components of the miRNA machinery to
the mitochondria awaits future studies.
Enhanced Translation by the miRNA/Ago2 Complex in
the Mitochondria
We provided a series of evidence for direct action of the miRNA/
Ago2 complex in enhancing mitochondrial translation, including
(1) direct Ago2 binding to specific mtDNA-encoded transcripts,
(2) the requirement for specific base-pairing interactions to elicit
the effect, (3) functional rescue of Ago2 knockout MEFs with
mitochondria-targeted Ago2, and (4) selective inactivation ofthe miRNA machinery in the cytoplasm by GW182 knockdown.
The latter two pieces of information demonstrate that miR-1 is
able to stimulate mitochondrial translation when the miRNA
machinery is selectively inactivated in the cytoplasm.
It is currently unclear how the miRNA/Ago2 complex precisely
augments mitochondrial translation. In fact, this is related to a
fundamental question with respect to translation initiation in
the mitochondria, despite of extensive efforts in the past de-
cades. This is because the fully processed mitochondrial tran-
scripts do not contain a cap structure (a key feature of eukaryotic
cytoplasmic mRNAs) nor contain any identifiable ribosomal
binding site (a mechanism used by bacteria). Based on our
Ago2 mapping data, it is curious to note extensive interactions
of Ago2 with the 12S rRNA. We also observed extensive
association of Ago2 with mitochondrial transcripts, some with
more specific interactions while others in a more continuous
fashion as if those transcripts are ‘‘wrapped’’ around the Ago2-
containing complex. As such, Ago2 may function as a key
mitochondrial translation initiation factor to facilitate ribosome-
mRNA interactions.A Coordinated Myogenic Program Regulated by miR-1
Our findings also extend the physiological function of miR-1 in
skeletal and cardiac muscle. Genetic ablation of this miRNA
demonstrated a profound effect on heart functions in the mouse
(Zhao et al., 2007). However, as the heart contains fully differen-
tiated cardiomyocytes in adult, it has been unclear how this
miRNA might contribute to muscle physiology. Our data demon-
strate that this miRNA is able to boost ATP production in the
mitochondria, which is in high demand for heart contraction,
thus providing a plausible explanation for its functional require-
ment in the heart.
Published studies have demonstrated a vital role of miR-1 in
inhibiting HDAC4 (Chen et al., 2006), which suppresses Mef2
(Arnold et al., 2007), and elevated Mef2 further activates the
expression of miR-1 (Liu et al., 2007), thereby forming an autor-
egulatory loop to maintain the myogenic program. Our data add
a further role of miR-1 in enhancing protein synthesis and ATP
production in the mitochondria of differentiated muscle cells
and suggest miR-1 in coordinating regulatory networks in both
the cytoplasm and the mitochondria during and after muscle dif-
ferentiation, as illustrated in Figure 6E. Therefore, the newly
elucidated role of the miRNA complex in the mitochondria sug-
gests a new layer of crosstalk between nuclear and mitochon-
drial genomes in eukaryotic cells.EXPERIMENTAL PROCEDURES
Isolation of Mitochondria and Purification of Mitoplasts
Cardiomyocytes from mouse heart, C2C12-derived myoblasts or myotubes
were collected by centrifugation, homogenized in a prechilled Dounce ho-
mogenizer (Kontes), and postnuclear supernatant collected. Mitochondria
were sedimented at 13,000 3 g for 10 min, washed once in the same buffer,
and further purified by centrifugation at 40,000 3 g for 1 hr at 4C on a
sucrose gradient (17%, 31%, 42%, 50%) in T10E20 buffer (10 mM Tris-
HCl pH 7.4, 20 mM EDTA). Purification of mitoplasts was according to
the previous procedure (Schnaitman and Greenawalt, 1968). Table S3
lists specific microRNA mimics and antagomirs tested on mitochondrial
transcripts.Cell 158, 607–619, July 31, 2014 ª2014 Elsevier Inc. 617
Trypsin/Nuclease Protection Assays
For trypsin protection, isolated mitochondria and mitoplasts were either kept
on ice as control or treated with Trypsin (100 mg/ml) alone or with Trypsin
(100 mg/ml) plus Triton X-100 (1%). Treated mitochondria or mitoplasts were
collected by centrifugation at 18,0003 g for 3 min and the pellets were resus-
pended in SDS-PAGE sample buffer for western blotting. The nuclease protec-
tion was similarly performed on isolated mitochondria and mitoplasts with
RNase T1 (3,000 U/ml) plus Micrococcal nuclease (1,000 U/ml) digestion on
ice for 30 min in the presence or absence of Triton X-100. RNA was extracted
with Trizol from pelleted mitochondria or mitoplasts for RT-qPCR. PCR
primers and probes are listed in Table S4.
Analysis of Mitochondrial Translation by Polysome Profiling
Sucrose gradient sedimentation of mitochondrial ribosome/polysome was
carried out as described (Antonicka et al., 2013). Briefly, mitochondria purified
from C2C12 myoblasts or myotubes were suspended in the lysis buffer
(260 mM sucrose, 100 mM KCl, 20 mM MgCl2, 10 mM Tris-pH 7.5, 1% Triton
X-100, 5 mM b-mercaptoethanol, and a cocktail of protease inhibitors from
Roche) on ice for 20 min. The lysate was centrifuged at 9,000 3 g for 30 min
to remove particles, loaded on an 8ml 10%–30% sucrose gradient, and centri-
fuged at 180,0003 g for 260min in a Beckman SW41-Ti rotor. To characterize
putative polysomes, the lysate was treated with 5 U/ml RNase I for 40 min at
25C. After centrifugation, 13 fractions were collected for RNA and protein
analysis.
Detection of Nascent Protein Synthesis
Click-iT reagents (Life Technology) were used to label nascent polypeptides.
C2C12 myoblasts were first transfected with miRNA or control RNA at 30%–
40% confluence in 24-well plates. After culturing overnight, the plate was
washed three times with prewarmed PBS. The cells were incubated in methi-
onine-free DMEM for 45 min followed by the addition of 20 mMof Emetine, and
incubated for another 15 min. The media were replaced with methionine-free
DMEM containing 50 mMmethionine analog AHA and 20 mMEmetine. After in-
cubation for 4 hr, AHA-containing nascent proteins were labeled with TAMRA
(Life Technology), resolved in 4%–12% gradient SDS-PAGE, and analyzed by
Typhoon 9400. These and other methods are detailed in Extended Experi-
mental Procedures.
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